Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384 –390

Agence Nationale de S écurité du Médicament et des Produits de Santé10.13039/5011000075432019S015
Source: Diabetes Care - Category: Endocrinology Source Type: research